Translational Cancer Research is indexed in SCIE

Published: 2015-10-03

Nancy Q. Zhong
Editorial Office, AME Publishing Company, Guangzhou 510220, China
Correspondence to: Nancy Q. Zhong. Editorial Office, AME Publishing Company, Guangzhou 510220, China. Email:

In October 2015, Translational Cancer Research (TCR) was selected for coverage in Science Citation Index Expanded (SCIE), service of Thomson Reuters. TCR Articles from Volume 1, Number 1 will be indexed well in the database and searchable online at the Web of KnowledgeTM core collection. 

Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; is an open access, peer review journal published bimonthly both in print and online. Published and run by AME Publishing Company, the operation of TCR journal is driven by the leadership and passion of Editor-in-Chief, Prof. Eric Chuang (National Taiwan University); co-Editor-in- Chief, Dr. Huan Giap (Scripps Proton Therapy Center). Dr. Binghe Xu (Cancer Hospital and Institute, Chinese Academy of Medical Sciences) joined the journal as Associate Editor-in-Chief from 2014. They devote their time and bring their decades of experience in scientific research and publications for managing this journal. 

The indexation of TCR journal 3 years upon its lunch in the important database of SCIE is a landmark to the journal. Since its launch in June 2012, TCR journal has been publishing timely and high-quality original article, review article as well as other article types authored by important researchers and clinicians in the field. The indexation makes these important articles part of the over 1 billion searchable, cited references in Web of Science, allowing TCR articles to be linked with studies of more researchers and clinicians internationally. Without any doubts, the database would increase the impact of TCR journal among other publications; at the meantime, the journal would add more significance to the database as well.